Adaptimmune Therapeutics plc (ADAP)
NASDAQ: ADAP · IEX Real-Time Price · USD
1.580
0.00 (0.00%)
At close: Mar 28, 2024, 4:00 PM
1.560
-0.020 (-1.27%)
After-hours: Mar 28, 2024, 7:37 PM EDT

Adaptimmune Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Cash & Equivalents
147.02109.6151.6761.4854.9172.4888.3185.49284.34
Short-Term Investments
2.9596.57219.63311.3439.13136.76124.2200
Cash & Cash Equivalents
149.96206.17371.3372.8294.04209.23212.51185.49284.34
Cash Growth
-27.26%-44.47%-0.41%296.46%-55.06%-1.54%14.57%-34.76%-
Receivables
0.827.440.750.1400.190.211.480
Other Current Assets
56.7741.7643.4125.1926.4521.6717.4611.7810.74
Total Current Assets
207.55255.37415.46398.15120.49231.1230.18198.75295.08
Property, Plant & Equipment
71.7171.5451.3746.6651.8636.1240.6827.95.39
Goodwill and Intangibles
0.330.4411.732.21.471.341.270.18
Other Long-Term Assets
3.031.571.724.678.058.956.60
Total Long-Term Assets
75.0673.5554.0952.9961.0545.6450.9635.765.57
Total Assets
282.62328.92469.55451.14181.54276.74281.15234.52300.65
Accounts Payable
8.134.758.116.396.364.088.3811.351.98
Deferred Revenue
178.03184.41199.4252.092.13038.7436.3535.79
Current Debt
5.382.732.322.772.490000
Other Current Liabilities
-118.76-127.39-147.31-22.1823.3620.3527.2-7.43-11.01
Total Current Liabilities
72.7964.562.5439.0734.3424.4474.3140.2726.77
Long-Term Debt
19.8520.3523.1520.9422.970000
Other Long-Term Liabilities
150.46162.19177.949.90.65.413.8528.114.89
Total Long-Term Liabilities
170.32182.54201.0470.8423.565.413.8528.114.89
Total Liabilities
243.1247.04263.59109.9257.9129.8578.1668.3741.65
Total Debt
25.2423.0825.4723.7125.460000
Debt Growth
9.35%-9.39%7.41%-6.87%-----
Retained Earnings
-1,023.17-909.3-743.85-585.76-455.66-318.5-231.63-161.49-66.91
Comprehensive Income
-3.75-0.88-11.14-10.05-7.26-9.76-21.64-14.25-3.56
Shareholders' Equity
39.5181.88205.96341.23123.64246.89202.98166.14259
Net Cash / Debt
124.73183.1345.83349.1168.58209.23212.51185.49284.34
Net Cash / Debt Growth
-31.88%-47.06%-0.94%409.06%-67.22%-1.54%14.57%-34.76%-
Net Cash Per Share
0.100.190.370.410.110.360.400.441.32
Working Capital
134.76190.87352.92359.0886.15206.66155.87158.48268.32
Book Value Per Share
0.200.511.322.401.182.542.312.357.24
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).